COVID-19 test positivity: predictive value of various symptoms in a large community-based testing program in California
View ORCID ProfileDave P. Miller, Scott Morrow, Robert M. Califf, Cameron Kaiser, Ritu Kapur, Casimir Starsiak III, Jessica Mega, William J. Marks Jr.
doi: https://doi.org/10.1101/2021.03.03.21252014
Dave P. Miller
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
MSScott Morrow
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
MD, MPH, MBARobert M. Califf
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
MDCameron Kaiser
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
MD, MPHRitu Kapur
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
PhDCasimir Starsiak III
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
MSJessica Mega
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
MD, MPHWilliam J. Marks Jr.
Verily Life Sciences (DPM, RMC, RK, CS, JM and WM); San Mateo County (SM); Riverside County (CK)
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data are only available in aggregate form, as presented in the paper. Due to the presence of protected health information (PHI), which is critical for meaningful analysis, in the form of test dates and county-level geographic identifiers, it is not possible to deidentify or anonymize the data to be shared beyond the presentation of aggregate data.
Posted March 05, 2021.
COVID-19 test positivity: predictive value of various symptoms in a large community-based testing program in California
Dave P. Miller, Scott Morrow, Robert M. Califf, Cameron Kaiser, Ritu Kapur, Casimir Starsiak III, Jessica Mega, William J. Marks Jr.
medRxiv 2021.03.03.21252014; doi: https://doi.org/10.1101/2021.03.03.21252014
COVID-19 test positivity: predictive value of various symptoms in a large community-based testing program in California
Dave P. Miller, Scott Morrow, Robert M. Califf, Cameron Kaiser, Ritu Kapur, Casimir Starsiak III, Jessica Mega, William J. Marks Jr.
medRxiv 2021.03.03.21252014; doi: https://doi.org/10.1101/2021.03.03.21252014
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2661)
- Dermatology (224)
- Emergency Medicine (402)
- Epidemiology (12264)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2670)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (442)
- Neurology (3912)
- Nursing (210)
- Nutrition (582)
- Oncology (2048)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (455)
- Public and Global Health (6551)
- Radiology and Imaging (1410)
- Respiratory Medicine (872)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)